How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "sCD-HeFT Criteria?"

American Journal of Cardiology

Volumn 109, Issue 5, 2012, Pages 729-735

  Zecchin, Massimo ^a   Merlo, Marco ^a   Pivetta, Alberto ^a   Barbati, Giulia ^b   Lutman, Cristina ^a   Gregori, Dario ^b   Serdoz, Laura Vitali ^a   Bardari, Stefano ^a   Magnani, Silvia ^a   Di Lenarda, Andrea ^c   Proclemer, Alessandro ^d   Sinagra, Gianfranco ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Cardiovascular Center   (Italy)

^d UNIVERSITY HOSPITAL OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; METOPROLOL;

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SUDDEN DEATH; TREATMENT INDICATION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOMYOPATHY, DILATED; DEFIBRILLATORS, IMPLANTABLE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UNNECESSARY PROCEDURES;

EID: 84857627713     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.10.033     Document Type: Article

References (22)

1. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, R. Boineau, M. Domanski, C. Troutman, J. Anderson, G. Johnson, S.E. McNulty, N. Clapp-Channing, L.D. Davidson-Ray, E.S. Fraulo, D.P. Fishbein, R.M. Luceri, J.H. Ip Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237 (Pubitemid 40110811)
2. A. Kadish, A. Dyer, J.P. Daubert, R. Quigg, N.A. Estes, K.P. Anderson, H. Calkins, D. Hoch, J. Goldberger, A. Shalaby, W.E. Sanders, A. Schaechter, J.H. Levine Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158 (Pubitemid 38637995)
3. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, N.A. Estes III, R.A. Freedman, L.S. Gettes, A.M. Gillinov, G. Gregoratos, S.C. Hammill, D.L. Hayes, M.A. Hlatky, L.K. Newby, R.L. Page, M.H. Schoenfeld, M.J. Silka, L.W. Stevenson, M.O. Sweeney, S.C. Smith Jr, A.K. Jacobs, C.D. Adams, J.L. Anderson, C.E. Buller, M.A. Creager, S.M. Ettinger, D.P. Faxon, J.L. Halperin, L.F. Hiratzka, S.A. Hunt, H.M. Krumholz, F.G. Kushner, B.W. Lytle, R.A. Nishimura, J.P. Ornato, R.L. Page, B. Riegel, L.G. Tarkington, C.W. Yancy ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons J Am Coll Cardiol 51 2008 e1 e62
4. S.M. Al-Khatib, A. Hellkamp, J. Curtis, D. Mark, E. Peterson, G.D. Sanders, P.A. Heidenreich, A.F. Hernandez, L.H. Curtis, S. Hammill Non-evidence-based ICD implantations in the united states JAMA 305 2011 43 49
5. H.T. Aretz Myocarditis: the Dallas criteria Hum Pathol 18 1987 619 624 (Pubitemid 17097832)
6. P.A. Poole-Wilson, K. Swedberg, J.G. Cleland, A. Di Lenarda, P. Hanrath, M. Komajda, J. Lubsen, B. Lutiger, M. Metra, W.J. Remme, C. Torp-Pedersen, A. Scherhag, A. Skene Carvedilol or Metoprolol European Trial Investigators Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol European trial (COMET): randomised controlled trial Lancet 362 2003 7 13 (Pubitemid 36835815)
7. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, J. Wittes Randomized Aldactone Evaluation Study Investigators The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 1999 709 717 (Pubitemid 29407370)
8. G. Gregoratos, J. Abrams, A.E. Epstein, R.A. Freedman, D.L. Hayes, M.A. Hlatky, R.E. Kerber, G.V. Naccarelli, M.H. Schoenfeld, M.J. Silka, S.L. Winters, R.J. Gibbons, E.M. Antman, J.S. Alpert, G. Gregoratos, L.F. Hiratzka, D.P. Faxon, A.K. Jacobs, V. Fuster, S.C. Smith Jr ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to update the 1998 pacemaker guidelines) Circulation 106 2002 2145 2161 (Pubitemid 35192824)
9. M. Zecchin, A. Di Lenarda, A. Proclemer, G. Faganello, D. Facchin, E. Petz, G. Sinagra The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy Europace 6 2004 400 406 (Pubitemid 39117845)
10. J.P. Vandenbroucke, E. von Elm, D.G. Altman, P.C. Gøtzsche, C.D. Mulrow, S.J. Pocock, C. Poole, J.J. Schlesselman, M. Egger STROBE Initiative Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration Ann Intern Med 147 2007 W163 W194
11. P.P. Rickham Human experimentation: code of ethics of the world medical association Declaration of Helsinki BMJ 2 1964 177
12. R. Tung, P. Zimetbaum, M.E. Josephson A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death J Am Coll Cardiol 52 2008 1111 1121
13. S.A. Hall, C.G. Cigarroa, L. Marcoux, R.C. Risser, P.A. Grayburn, E.J. Eichhorn Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade J Am Coll Cardiol 25 1995 1154 1161
14. M. Metra, S. Nodari, G. Parrinello, R. Giubbini, C. Manca, L. Dei Cas Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance Am Heart J 145 2003 292 299 (Pubitemid 36207951)
15. A. Verma, Z. Wulffhart, D. Lakkireddy, Y. Khaykin, A. Kaplan, B. Sarak, M. Biria, J. Pillarisetti, P. Bhat, L. Di Biase, O. Constantini, K. Quan, A. Natale Incidence of left ventricular function improvement after primary prevention ICD implantation for non-ischaemic dilated cardiomyopathy: a multicentre experience Heart 96 2010 510 515
16. A. DiLenarda, D. Gregori, G. Sinagra, G. Lardieri, A. Perkan, B. Pinamonti, L. Salvatore, G. Secoli, M. Zecchin, F. Camerini The Heart Muscle Disease Study Group Metoprolol in dilated cardiomyopathy: is it possible to identify factors predictive of improvement? J Card Fail 2 1996 87 102 (Pubitemid 126666358)
17. W. Grimm, M. Christ, J. Bach, H.H. Mller, B. Maisch Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg cardiomyopathy study Circulation 108 2003 2883 2891 (Pubitemid 37517816)
18. C. Raphael, C. Briscoe, J. Davies, Z. Ian Whinnett, C. Manisty, R. Sutton, J. Mayet, D.P. Francis Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure Heart 93 2007 476 482 (Pubitemid 46631515)
19. M. Zecchin, A. Di Lenarda, D. Gregori, M. Merlo, A. Pivetta, G. Vitrella, G. Sabbadini, L. Mestroni, G. Sinagra Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment? Pacing Clin Electrophysiol 31 2008 290 299 (Pubitemid 351328746)
20. A. Kadish, A. Schaechter, H. Subacius, E. Thattassery, W. Sanders, K.P. Anderson, A. Dyer, J. Goldberger, J. Levine Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators J Am Coll Cardiol 47 2006 2477 2482 (Pubitemid 43884774)
21. D. Bnsch, M. Antz, S. Boczor, M. Volkmer, J. Tebbenjohanns, K. Seidl, M. Block, F. Gietzen, J. Berger, K.H. Kuck Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the cardiomyopathy trial (CAT) Circulation 105 2002 1453 1458 (Pubitemid 34263277)
22. B. Pinamonti, M. Zecchin, A. Di Lenarda, D. Gregori, G. Sinagra, F. Camerini Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign J Am Coll Cardiol 29 1997 604 612 (Pubitemid 27116104)